Skip to main content

Currently Skimming:

1 Introduction
Pages 1-10

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 1...
... Statements, recommendations, and opinions expressed are those of individual presenters and participants and are not necessarily endorsed or verified by the National Academies of Sciences, Engineering, and Medicine, and they should not be construed as reflecting any group consensus. 2 The following list of key messages is the rapporteurs' summary of points made by the individual speakers identified, and the statements have not been endorsed or verified by the National Academies of Sciences, Engineering, and Medicine.
From page 2...
... National Personal Protective Technology Laboratory (NPPTL) is responsible for POAM 23 of the National Strategy: Launching a New Product Standardization Task Force.4 The objective of POAM 23 is to convene a task force of experts who would work to improve the efficacy, effective use, safety, supply stability, and accessibility of PPE and PPT that would be used (1)
From page 3...
... The task force's work was informed by a NIOSH-hosted workshop on equitable PPE protection workshop held in November 2022,6 which identified potential PPE standards gaps associated with PPE equity, as well as a meeting of the National Academies Committee on Personal Protective Equipment for Workplace Safety and Health in December 2022. This latter meeting focused on all NIOSH Approved®7 air-purifying respirators and additional PPE standards issues associated with respirator use in health care.
From page 4...
... The workshop will feature invited presentations and discussions to • Examine issues that arose during the COVID-19 pandemic associated with current product standards for PPT and PPE, with a focus on PPE sizing standards; • Explore potential supply chain impacts associated with product and tech nology standards, including those related to stockpiling of PPE and PPE sizing standards; • Discuss standards needs for health care and critical infrastructure work ers and the public (e.g., sizing, fit testing) , as well as opportunities, bar riers, and potential solutions to addressing current PPE limitations; • Highlight relevant intellectual property issues related to PPE standardization; • Consider how standards can improve the effectiveness of PPE without impeding innovation; and • Consider how input received in response to past NIOSH Federal Register Notices (FRNs)
From page 5...
... Chapter 9 presents potential approaches to prioritizing efforts to fill gaps in standards, and Chapter 10 recounts a final discussion on a cohesive and complex standards system for a resilient supply chain. Appendix A contains the workshop agenda and Appendix B provides biographical sketches of the speakers, session moderators, and project staff.
From page 6...
... , stressed that the use of respirators and masks is important for infection control, he also emphasized that it is important to understand that masks and respirators are distinct types of PPE. Respirators are devices designed to protect the user from inhaling hazardous atmospheres including fumes, vapors, gases, particulate matter, and airborne infectious agents, and operate by either removing contaminants from the air (filtering)
From page 7...
... NOTE: AAMI = Association for the Advancement of Medical Instrumentation; ANSI = American National Standards Institute; ISEA = International Safety Equipment Association; NFPA = National Fire Protection Association SOURCE: Presented by Jeffrey Stull on March 2, 2023, at the PPE/PPT Standardization for a Resilient Public Health Supply Chain Workshop.
From page 8...
... Department of Health and Human Services (HHS) and is registered in the United States and several international jurisdictions (Cichowicz and D'Alessandro, 2020; NIOSH, 2022a)
From page 9...
... However, they do not filter or block very small particles in the air that may be transmitted by coughs, sneezes, or certain medical procedures. These are cleared by the FDA for use in sterile health care settings but are not NIOSH Approved® respirators (FDA, 2023b; NIOSH, 2021a)


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.